FBTU.L vs. IHE
FBTU.L (First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds. Over the past 5 years, FBTU.L returned 6.94%/yr vs 10.57%/yr for IHE. At a 0.41 correlation, their price movements are largely independent. FBTU.L charges 0.60%/yr vs 0.42%/yr for IHE.
Performance
FBTU.L vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBTU.L achieves a 8.73% return, which is significantly lower than IHE's 9.33% return.
FBTU.L
- 1D
- 4.34%
- 1M
- 9.71%
- YTD
- 8.73%
- 6M
- 6.95%
- 1Y
- 38.25%
- 3Y*
- 13.28%
- 5Y*
- 6.94%
- 10Y*
- —
IHE
- 1D
- 2.69%
- 1M
- 3.48%
- YTD
- 9.33%
- 6M
- 12.42%
- 1Y
- 43.59%
- 3Y*
- 18.33%
- 5Y*
- 10.57%
- 10Y*
- 7.97%
FBTU.L vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBTU.L First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating | 8.73% | 25.95% | 4.74% | 3.91% | -5.96% | -3.77% | 3.88% |
IHE iShares U.S. Pharmaceuticals ETF | 9.33% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 15.06% |
Correlation
The correlation between FBTU.L and IHE is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2020 | 0.41 |
The correlation between FBTU.L and IHE has been stable across timeframes, ranging from 0.41 to 0.51 - a consistent structural relationship.
FBTU.L vs. IHE - Sectors Allocation Comparison
Sectors
FBTU.L
IHE
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBTU.L
IHE
Basic Materials
FBTU.L
-
IHE
-
Communication Services
FBTU.L
-
IHE
-
Consumer Cyclical
FBTU.L
-
IHE
-
Consumer Defensive
FBTU.L
-
IHE
-
Energy
FBTU.L
-
IHE
-
Financial Services
FBTU.L
-
IHE
-
Industrials
FBTU.L
-
IHE
-
Real Estate
FBTU.L
-
IHE
-
Technology
FBTU.L
-
IHE
-
Utilities
FBTU.L
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBTU.L vs. IHE — Risk / Return Rank
FBTU.L
IHE
FBTU.L vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTU.L | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.43 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 2.66 | 5.17 | -2.51 |
| Martin ratioReturn relative to average drawdown | 7.17 | 15.58 | -8.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBTU.L | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.79 | 2.54 | -0.75 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 0.65 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.44 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.51 | -0.24 |
Drawdowns
FBTU.L vs. IHE - Drawdown Comparison
The maximum FBTU.L drawdown since its inception was -33.73%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FBTU.L and IHE.
Loading charts...
Drawdown Indicators
| FBTU.L | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.73% | -38.20% | +4.47% |
Max Drawdown (1Y)Largest decline over 1 year | -14.30% | -8.47% | -5.83% |
Max Drawdown (3Y)Largest decline over 3 years | -22.47% | -15.92% | -6.55% |
Max Drawdown (5Y)Largest decline over 5 years | -29.97% | -16.03% | -13.94% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.59% | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.18% | +0.18% |
Average DrawdownAverage peak-to-trough decline | -13.11% | -7.92% | -5.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.32% | 2.81% | +2.51% |
Volatility
FBTU.L vs. IHE - Volatility Comparison
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) has a higher volatility of 7.25% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 6.04%. This indicates that FBTU.L's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBTU.L | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.25% | 6.04% | +1.21% |
Volatility (6M)Calculated over the trailing 6-month period | 16.34% | 12.70% | +3.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.31% | 17.26% | +4.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.91% | 16.28% | +4.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.38% | 18.07% | +3.31% |
FBTU.L vs. IHE - Expense Ratio Comparison
FBTU.L has a 0.60% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
FBTU.L vs. IHE - Dividend Comparison
FBTU.L has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTU.L First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.61% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
FBTU.L and IHE have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHE is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHE is cheaper with a 0.42% expense ratio, compared with 0.60% for FBTU.L.
They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FBTU.L and 0.42% for IHE.
Find the right allocation for FBTU.L and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer